prednisolone has been researched along with Menopause in 35 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This trial was conducted to determine if the reported superiority of tamoxifen (TAM) plus prednisolone (PRDLN) over TAM alone in postmenopausal women with metastatic breast cancer could be corroborated." | 9.07 | A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic. ( Etzell, PS; Gerstner, JG; Gesme, DH; Ingle, JN; Krook, JE; Long, HJ; Mailliard, JA; Pfeifle, DM; Schaid, DJ; Windschitl, HE, 1991) |
| "Serum sex hormone binding globulin (SHBG) was measured in 21 pre and 39 postmenopausal women with advanced breast cancer before treatment and 1, 3, 6, 9 and 12 months after ovarian irradiation or during continuous administration of tamoxifen at a dose of 10 mg twice daily, respectively; some patients received additional prednisolone at a dose of 5 mg twice a day." | 9.06 | Effects of prednisolone on sex hormone binding globulin during primary endocrine treatment of advanced breast cancer. ( Bulbrook, RD; Clark, GM; Moore, JW; Rubens, RD; Wang, DY, 1988) |
| "Various plasma hormones were measured in 13 pre- and 20 post-menopausal women with advanced breast cancer before and for 12 months after ovarian irradiation or during continuous administration of tamoxifen at a dose of 10 mg twice a day, respectively; some patients received additional prednisolone at a dose of 5 mg twice a day." | 9.05 | Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer. ( Blackburn, AM; Bulbrook, RD; Hoare, SA; Kwa, HG; Rubens, RD; Thomas, BS; Wang, DY, 1984) |
| "The sex hormones dehydroepiandrosterone sulphate (DHEAS), oestradiol, and sex hormone binding globulin (SHBG) were measured in 185 postmenopausal women (aged 45-65 years) with rheumatoid arthritis (RA) and related to assessments of bone mineral density at the spine and proximal femur." | 7.68 | Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. ( Hall, GM; Perry, LA; Spector, TD, 1993) |
| " The bioavailability and volume of distribution of prednisolone were unaffected by menopausal status." | 5.29 | The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics. ( Benet, LZ; Harris, RZ; Mroczkowski, P; Tsunoda, SM; Wong, H, 1996) |
| "This trial was conducted to determine if the reported superiority of tamoxifen (TAM) plus prednisolone (PRDLN) over TAM alone in postmenopausal women with metastatic breast cancer could be corroborated." | 5.07 | A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic. ( Etzell, PS; Gerstner, JG; Gesme, DH; Ingle, JN; Krook, JE; Long, HJ; Mailliard, JA; Pfeifle, DM; Schaid, DJ; Windschitl, HE, 1991) |
| "Serum sex hormone binding globulin (SHBG) was measured in 21 pre and 39 postmenopausal women with advanced breast cancer before treatment and 1, 3, 6, 9 and 12 months after ovarian irradiation or during continuous administration of tamoxifen at a dose of 10 mg twice daily, respectively; some patients received additional prednisolone at a dose of 5 mg twice a day." | 5.06 | Effects of prednisolone on sex hormone binding globulin during primary endocrine treatment of advanced breast cancer. ( Bulbrook, RD; Clark, GM; Moore, JW; Rubens, RD; Wang, DY, 1988) |
| "Various plasma hormones were measured in 13 pre- and 20 post-menopausal women with advanced breast cancer before and for 12 months after ovarian irradiation or during continuous administration of tamoxifen at a dose of 10 mg twice a day, respectively; some patients received additional prednisolone at a dose of 5 mg twice a day." | 5.05 | Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer. ( Blackburn, AM; Bulbrook, RD; Hoare, SA; Kwa, HG; Rubens, RD; Thomas, BS; Wang, DY, 1984) |
| "The sex hormones dehydroepiandrosterone sulphate (DHEAS), oestradiol, and sex hormone binding globulin (SHBG) were measured in 185 postmenopausal women (aged 45-65 years) with rheumatoid arthritis (RA) and related to assessments of bone mineral density at the spine and proximal femur." | 3.68 | Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. ( Hall, GM; Perry, LA; Spector, TD, 1993) |
| "Thirty-one patients with rheumatoid arthritis maintained on prednisolone 5 mg daily for an average period of 9." | 3.67 | Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. ( Hajiroussou, VJ; Webley, M, 1984) |
| " The studies were performed to examine a possible difference between right and left oviducts, age-related differences, changes due to the menstrual cycle and pregnancy, and the effects of various drugs such as antibiotics, urokinase and corticosteroid (prednisolone)." | 3.67 | [Cilium movement of human oviduct]. ( Yamaoka, S, 1987) |
| "Tamoxifen alone was given to 26 women, and 20 received additional prednisolone." | 2.67 | Tamoxifen protects against steroid-induced bone loss. ( Caleffi, M; Chaudary, MA; Fentiman, IS; Fogelman, I; Saad, Z, 1992) |
| "Seventy patients with breast cancer (stage IIIb--IV) were randomized by an "envelope" method into 2 groups, each including 35 persons." | 2.64 | [Combined drug treatment of far-advanced forms of breast cancer]. ( Borisov, AI, 1978) |
| "Renal biopsy indicated Class V + IV(G)-A lupus nephritis (LN)." | 1.48 | Pulmonary lymphangioleimyomatosis and systemic lupus erythematosus in a menopausal woman. ( Hong, H; Li, X; Ma, Z; Wang, M; Yang, R, 2018) |
| "We conclude that menopause affects the bone turnover in RA as well as in normal controls." | 1.30 | The effects of menopausal status and disease activity on biochemical markers of bone metabolism in female patients with rheumatoid arthritis. ( Hoshino, H; Inoue, T; Kushida, K; Miura, M; Miyamoto, S; Suzuki, M; Takahashi, M, 1998) |
| " Prednisolone therapy in 22 patients (mean dosage 8 mg/day) was associated with reductions in estrone and testosterone levels; however, DHEAS and femoral BMD were also decreased in RA patients who were not receiving corticosteroids." | 1.27 | Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. ( Champion, GD; Eisman, JA; Pocock, NA; Sambrook, PN, 1988) |
| "Osteoporosis is a common complication of corticosteroid therapy and it is associated with both decreased bone formation and increased bone resorption." | 1.27 | Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women. ( Hartley, TF; Need, AG; Nordin, BE; Philcox, JC, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (68.57) | 18.7374 |
| 1990's | 7 (20.00) | 18.2507 |
| 2000's | 1 (2.86) | 29.6817 |
| 2010's | 3 (8.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, H | 1 |
| Yang, R | 1 |
| Li, X | 1 |
| Wang, M | 1 |
| Ma, Z | 1 |
| Tuin, J | 1 |
| Sanders, JS | 1 |
| van Beek, AP | 1 |
| Hoek, A | 1 |
| Stegeman, CA | 1 |
| Earnest, BS | 1 |
| Men, LC | 1 |
| Sukvinder Kaur, G | 1 |
| Alias, RB | 1 |
| Sunita Devi, H | 1 |
| HEATHER, AJ | 1 |
| SCHMID, J | 1 |
| IRVINE, WT | 1 |
| Brandenburg, VM | 1 |
| Ketteler, M | 1 |
| Heussen, N | 1 |
| Politt, D | 1 |
| Frank, RD | 1 |
| Westenfeld, R | 1 |
| Ittel, TH | 1 |
| Floege, J | 1 |
| Blackburn, AM | 1 |
| Wang, DY | 3 |
| Bulbrook, RD | 2 |
| Thomas, BS | 1 |
| Kwa, HG | 1 |
| Hoare, SA | 1 |
| Rubens, RD | 4 |
| Hajiroussou, VJ | 1 |
| Webley, M | 1 |
| Stewart, JF | 1 |
| King, RJ | 1 |
| Minton, MJ | 1 |
| Steiner, R | 1 |
| Tong, D | 2 |
| Winter, PJ | 2 |
| Knight, RK | 2 |
| Hayward, JL | 1 |
| Hall, GM | 1 |
| Perry, LA | 1 |
| Spector, TD | 1 |
| Harris, RZ | 1 |
| Tsunoda, SM | 1 |
| Mroczkowski, P | 1 |
| Wong, H | 1 |
| Benet, LZ | 2 |
| Suzuki, M | 1 |
| Takahashi, M | 1 |
| Miyamoto, S | 1 |
| Hoshino, H | 1 |
| Kushida, K | 1 |
| Miura, M | 1 |
| Inoue, T | 1 |
| Smallridge, RC | 1 |
| Wartofsky, L | 1 |
| Dimond, RC | 1 |
| Crilly, RG | 1 |
| Marshall, DH | 2 |
| Nordin, BE | 4 |
| Borisov, AI | 1 |
| Crilly, R | 1 |
| Fentiman, IS | 1 |
| Saad, Z | 1 |
| Caleffi, M | 1 |
| Chaudary, MA | 1 |
| Fogelman, I | 1 |
| Richards, MA | 1 |
| Coleman, RE | 2 |
| Hamsa, R | 1 |
| Khaled, H | 1 |
| el Mawla, MG | 1 |
| Kadry, I | 1 |
| Hablas, A | 1 |
| Ramadan, M | 1 |
| Allen, D | 1 |
| Ingle, JN | 1 |
| Mailliard, JA | 1 |
| Schaid, DJ | 1 |
| Krook, JE | 1 |
| Gesme, DH | 1 |
| Windschitl, HE | 1 |
| Pfeifle, DM | 1 |
| Etzell, PS | 1 |
| Gerstner, JG | 1 |
| Long, HJ | 1 |
| Smith, D | 1 |
| Dewar, JA | 1 |
| Horobin, JM | 1 |
| Scott, JS | 1 |
| Preece, PE | 1 |
| Hughes, GR | 1 |
| Sambrook, PN | 2 |
| Eisman, JA | 2 |
| Champion, GD | 2 |
| Pocock, NA | 2 |
| Gustavson, LE | 1 |
| Legler, UF | 1 |
| Tinson, CL | 1 |
| North, WR | 1 |
| Montecucco, C | 1 |
| Baldi, F | 1 |
| Fortina, A | 1 |
| Tomassini, G | 1 |
| Caporali, R | 1 |
| Cherie-Ligniere, EL | 1 |
| Fratino, P | 1 |
| Clark, GM | 1 |
| Moore, JW | 1 |
| Need, AG | 1 |
| Philcox, JC | 1 |
| Hartley, TF | 1 |
| Yamaoka, S | 1 |
| Yeates, MG | 1 |
| Eberl, S | 1 |
| Tamaoka, T | 1 |
| Gagliardi, L | 1 |
| Skripkin, IuK | 1 |
| Markin, IIa | 1 |
| Gallagher, JC | 1 |
| Aaron, J | 1 |
| Horsman, A | 1 |
| Wilkinson, R | 1 |
| Konoplia, EF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| CID 0708 - Sex, Aging and Antiretroviral Pharmacokinetics[NCT00666055] | 11 participants (Actual) | Observational | 2008-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisolone and Menopause
| Article | Year |
|---|---|
SELECTION AND TREATMENT OF PATIENTS WITH ADVANCED BREAST CANCER.
Topics: Adrenalectomy; Androgens; Breast; Breast Neoplasms; Cortisone; Estrogens; Female; Humans; Hypophysec | 1964 |
8 trials available for prednisolone and Menopause
| Article | Year |
|---|---|
Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; | 1984 |
Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer.
Topics: Adult; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Menopause; Ovary; Prednisolone; | 1982 |
[Combined drug treatment of far-advanced forms of breast cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Castration; Clinical Trials as Topic; Cyclophosphamide; Dru | 1978 |
Tamoxifen protects against steroid-induced bone loss.
Topics: Aged; Bone Density; Bone Resorption; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Predn | 1992 |
A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Breast Neoplasms; Double-Blind Method; Female; Humans; | 1991 |
Meakin adjuvant regimen in premenopausal patients with breast cancer.
Topics: Adult; Breast Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Me | 1990 |
Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.
Topics: Adult; Breast Neoplasms; Combined Modality Therapy; Drug Synergism; Female; Humans; Menopause; Middl | 1988 |
Effects of prednisolone on sex hormone binding globulin during primary endocrine treatment of advanced breast cancer.
Topics: Breast Neoplasms; Combined Modality Therapy; Female; Humans; Menopause; Ovary; Prednisolone; Radioth | 1988 |
26 other studies available for prednisolone and Menopause
| Article | Year |
|---|---|
Pulmonary lymphangioleimyomatosis and systemic lupus erythematosus in a menopausal woman.
Topics: Anti-Bacterial Agents; Cyclophosphamide; Drug Therapy, Combination; Fatal Outcome; Female; Humans; I | 2018 |
Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Case-Control Studie | 2016 |
Chronic hepatitis C infection associated with neuromyelitis optica and antinuclear antibodies.
Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Hepatitis C Antibodies; Hepatitis C, Chronic; Hum | 2010 |
TREATMENT OF OSTEOPOROSIS WITH AN ANABOLIC COMPOUND AND L-LYSINE.
Topics: Amino Acids; Anabolic Agents; Appetite; Arthritis; Arthritis, Rheumatoid; Dietary Proteins; Emotions | 1963 |
[CALCIUM THERAPY OF OSTEOPOROSIS. DETERMINATION OF BONE DENSITY AS A CRITERION].
Topics: Aging; Anabolic Agents; Arthritis; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Calcium; Ger | 1963 |
Lumbar bone mineral density in very long-term renal transplant recipients: impact of circulating sex hormones.
Topics: Adult; Aged; Anti-Inflammatory Agents; Bone Density; Dehydroepiandrosterone; Estradiol; Female; Foll | 2005 |
Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Bone and Bones; Female; Humans; Male; Menopause; Middle Aged; Osteoporosis; P | 1984 |
Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density.
Topics: Aged; Arthritis, Rheumatoid; Bone Density; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; E | 1993 |
The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biological Availability; Breath Tests; Cytoc | 1996 |
The effects of menopausal status and disease activity on biochemical markers of bone metabolism in female patients with rheumatoid arthritis.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, | 1998 |
Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormone.
Topics: Acromegaly; Female; Growth Hormone; Humans; Hyperthyroidism; Menopause; Methimazole; Middle Aged; Pr | 1979 |
Metabolic effects of corticosteroid therapy in post-menopausal women.
Topics: Androstenedione; Bone and Bones; Calcium; Creatinine; Dehydroepiandrosterone; Estradiol; Estrone; Fe | 1979 |
The relation between plasma androstenedione and oestrone levels in untreated and corticosteroid-treated post-menopausal women.
Topics: Adrenal Cortex Hormones; Adult; Aged; Androstenedione; Castration; Estrone; Female; Humans; Menopaus | 1978 |
Advanced breast cancer in Egyptian women: clinical features and response to endocrine therapy. The Anglo-Egyptian Health Agreement Collaborative Study.
Topics: Adult; Breast Neoplasms; Combined Modality Therapy; Egypt; Female; Humans; Mastectomy; Menopause; Mi | 1992 |
A 47-year-old woman presenting with a 20-year history of SLE.
Topics: Estrogens; Female; Humans; Lupus Erythematosus, Systemic; Menopause; Middle Aged; Osteoporosis; Pred | 1989 |
Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Bone and Bones; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Femal | 1988 |
Impairment of prednisolone disposition in women taking oral contraceptives or conjugated estrogens.
Topics: Adult; Contraceptives, Oral; Estrogens, Conjugated (USP); Female; Humans; Hydrocortisone; Kinetics; | 1986 |
Serum osteocalcin (bone Gla-protein) following corticosteroid therapy in postmenopausal women with rheumatoid arthritis. Comparison of the effect of prednisone and deflazacort.
Topics: Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Calcium-Binding Proteins; Female; Humans; Men | 1988 |
Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women.
Topics: Aged; Aged, 80 and over; Calcium; Creatinine; Female; Humans; Hydroxyproline; Menopause; Middle Aged | 1986 |
[Cilium movement of human oviduct].
Topics: Adult; Age Factors; Anti-Bacterial Agents; Cilia; Fallopian Tubes; Female; Humans; In Vitro Techniqu | 1987 |
Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids.
Topics: Adult; Arthritis, Rheumatoid; Bone and Bones; Female; Humans; Menopause; Middle Aged; Osteoporosis; | 1986 |
[Urinary gonadotropin in gynecology with special reference to adrenocortical function].
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Animals; Castration; Clomip | 1966 |
[Gynecologic hormone-dependent tumors].
Topics: Androgens; Endometrium; Estrogens; Female; Humans; Menopause; Middle Aged; Ovary; Prednisolone; Uter | 1974 |
[Pathogenesis and treatment of patients with kraurosis vulvae].
Topics: Adult; Aged; Female; Humans; Menopause; Middle Aged; Ointments; Prednisolone; Testosterone; Testoste | 1974 |
Corticosteroid osteoporosis.
Topics: Adult; Aged; Aging; Arthritis, Rheumatoid; Asthma; Autoanalysis; Bone and Bones; Calcium; Calcium Ra | 1973 |
[The urinary excretion of estrogens in patients with far advanced breast cancer during treatment with prednisolone].
Topics: Adrenal Glands; Breast Neoplasms; Castration; Chromatography; Estradiol; Estriol; Estrogens; Estrone | 1968 |